Latest Remuneration News

Thor Energy secured A$6.56 million from the Molyhil sale, expanded its natural hydrogen portfolio with new Otway Basin licences, and advanced its HY-Range Project geochemistry survey during Q1 2026.

TrivarX appoints Dr Danielle Meyrick as CEO to spearhead clinical trials and commercialisation of its novel stable isotope MRI brain cancer imaging platform, with Phase 1 studies on track for completion this year.

Strategic Elements Ltd (ASX:SOR) advanced its Energy Ink™ technology and commenced a pilot deployment of its EdgeiQ system at a WA gold mine, while maintaining a solid cash position of A$2.87 million and no debt.

Red Sky Energy bolsters its Innamincka Dome operations with binding AFEs for new wells and a $5.2 million capital raise, targeting near-term production growth and cashflow.

Tyranna Resources has identified new gold anomalies at its Chinguar Gold Project and progressed licence security and bulk sampling plans at its Namibe Lithium and Caesium Project in Angola.

Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.

OncoSil Medical reported a 60% year-on-year increase in dose sales in Q3 FY26, boosted by expanding treatment centres and advancing clinical trials, while cost-cutting and a new manufacturing facility aim to underpin growth.

PYC Therapeutics fortified its balance sheet by $600 million and progressed key RNA therapeutic trials in Q1 2026, setting the stage for pivotal clinical data and regulatory submissions.

Recharge Metals has kicked off exploration at its Sunset Well Gold Project in WA, backed by a $6 million war chest and a leadership reshuffle bringing in geologist Luke Timmermans as CEO.

Way2VAT reported a 95% surge in Q1 FY26 revenue to $2.05 million, driven by its RBC acquisition and expanding client base, while preparing to launch an e-invoicing platform integrating AI-powered APAI technology.

Minerals 260 has locked in a $220 million funding deal with Franco-Nevada, combining royalty and equity financing to fast-track its 4.5Moz Bullabulling Gold Project. Strong drilling results and accelerated project work underpin a development timeline targeting first production by end 2028.

Vitrafy Life Sciences completed Phase II of its U.S. Military platelet cryopreservation study with strong results for a simplified no-wash process, accelerating commercial interest and progressing FDA device registration despite manufacturing delays.